{"id":5272,"date":"2019-05-10T08:30:28","date_gmt":"2019-05-10T08:30:28","guid":{"rendered":"https:\/\/www.dailyrounds.org\/blog\/?p=5272"},"modified":"2019-05-10T08:30:28","modified_gmt":"2019-05-10T08:30:28","slug":"government-may-allow-private-sector-to-use-key-drug-for-treating-tb","status":"publish","type":"post","link":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/","title":{"rendered":"Government may allow private sector to use key drug for treating TB"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-5273\" src=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg\" alt=\"\" width=\"939\" height=\"704\" srcset=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg 640w, https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi-300x225.jpg 300w, https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi-500x375.jpg 500w\" sizes=\"auto, (max-width: 939px) 100vw, 939px\" \/>The Union health ministry may allow the private sector to use bedaquiline, a controlled-access drug used in the treatment of multi-drug resistant tuberculosis (MDR-TB).<br \/>\nSince the drug has controlled access, bedaquiline is dispensed only by the government to people with MDR-TB. Now the health ministry jointly with the departments of health research, biotechnology and other related departments is considering an institutional mechanism to give bedaquiline to patients in the private sector. A health ministry official said that there is a huge pharma lobby that is building an argument for putting everyone on bedaquiline, but it doesn\u2019t work like that. &#8220;Even though it is being hailed as a wonder drug, it has side effects that include hearing loss. It\u2019s a new drug. So we don\u2019t really have adequate data on its long-term treatment outcome,\u201d he added.<br \/>\n\u201cPeople generally assume bedaquiline is safer than other drugs but they forget that compared to a 6-8 months course for other medicines, a bedaquiline-based regimen could go up to 18-24 months. The longer duration could have its effects that our experts are looking at,\u201d he added.<br \/>\nThe health ministry has started collecting data on the treatment outcome for all oral treatment regimens among Indians. \u201cAbout 20 patients in the private sector in Mumbai have been given conditional bedaquiline access by the government. But the entire private sector can be given access only if they strictly adhere to the drug-compliance regimen for complete cure and to stop the patient developing extremely drug-resistant TB,\u201d an official said. The United States Agency for International Development (USAID) has provided 22,000 doses of the drug to the government. \u201cWe don\u2019t want to deny patients newer drugs if it benefits them, so we are considering the idea,\u201d he added.<br \/>\nIn India around 2.1 million people have TB. Among them, an estimated 30,000 people have MDR-TB. Only 6500 patients are on the bedaquiline-based treatment regimen. The side effects of this treatment can include heart problems and hearing impairment. The drug costs Rs 28,000 per course, which means the cost per patient is Rs 1.12 lakh on medicine alone.<\/p>\n<p>Source: Hindustan Times.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Union health ministry may allow the private sector to use bedaquiline, a controlled-access drug used in the treatment of multi-drug resistant tuberculosis (MDR-TB). Since the drug has controlled access, bedaquiline is dispensed only by the government to people with MDR-TB. Now the health ministry jointly with the departments of health research, biotechnology and other [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":5273,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[5],"tags":[],"class_list":["post-5272","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Government may allow private sector to use key drug for treating TB - DailyRounds<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Government may allow private sector to use key drug for treating TB - DailyRounds\" \/>\n<meta property=\"og:description\" content=\"The Union health ministry may allow the private sector to use bedaquiline, a controlled-access drug used in the treatment of multi-drug resistant tuberculosis (MDR-TB). Since the drug has controlled access, bedaquiline is dispensed only by the government to people with MDR-TB. Now the health ministry jointly with the departments of health research, biotechnology and other [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyRounds\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-10T08:30:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DailyRounds\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DailyRounds\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/\"},\"author\":{\"name\":\"DailyRounds\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/f1f8f4904507b9ce4c90c65c9c06f454\"},\"headline\":\"Government may allow private sector to use key drug for treating TB\",\"datePublished\":\"2019-05-10T08:30:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/\"},\"wordCount\":358,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/Indiaindi.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/\",\"name\":\"Government may allow private sector to use key drug for treating TB - DailyRounds\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/Indiaindi.jpg\",\"datePublished\":\"2019-05-10T08:30:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/f1f8f4904507b9ce4c90c65c9c06f454\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/Indiaindi.jpg\",\"contentUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/Indiaindi.jpg\",\"width\":640,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Government may allow private sector to use key drug for treating TB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/\",\"name\":\"DailyRounds\",\"description\":\"Largest academic Doctors network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/f1f8f4904507b9ce4c90c65c9c06f454\",\"name\":\"DailyRounds\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/author\\\/minu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Government may allow private sector to use key drug for treating TB - DailyRounds","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/","og_locale":"en_US","og_type":"article","og_title":"Government may allow private sector to use key drug for treating TB - DailyRounds","og_description":"The Union health ministry may allow the private sector to use bedaquiline, a controlled-access drug used in the treatment of multi-drug resistant tuberculosis (MDR-TB). Since the drug has controlled access, bedaquiline is dispensed only by the government to people with MDR-TB. Now the health ministry jointly with the departments of health research, biotechnology and other [&hellip;]","og_url":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/","og_site_name":"DailyRounds","article_published_time":"2019-05-10T08:30:28+00:00","og_image":[{"width":640,"height":480,"url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","type":"image\/jpeg"}],"author":"DailyRounds","twitter_card":"summary_large_image","twitter_misc":{"Written by":"DailyRounds","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#article","isPartOf":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/"},"author":{"name":"DailyRounds","@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/f1f8f4904507b9ce4c90c65c9c06f454"},"headline":"Government may allow private sector to use key drug for treating TB","datePublished":"2019-05-10T08:30:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/"},"wordCount":358,"commentCount":0,"image":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/","url":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/","name":"Government may allow private sector to use key drug for treating TB - DailyRounds","isPartOf":{"@id":"https:\/\/www.dailyrounds.org\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#primaryimage"},"image":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","datePublished":"2019-05-10T08:30:28+00:00","author":{"@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/f1f8f4904507b9ce4c90c65c9c06f454"},"breadcrumb":{"@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#primaryimage","url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","contentUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","width":640,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/www.dailyrounds.org\/blog\/government-may-allow-private-sector-to-use-key-drug-for-treating-tb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dailyrounds.org\/blog\/"},{"@type":"ListItem","position":2,"name":"Government may allow private sector to use key drug for treating TB"}]},{"@type":"WebSite","@id":"https:\/\/www.dailyrounds.org\/blog\/#website","url":"https:\/\/www.dailyrounds.org\/blog\/","name":"DailyRounds","description":"Largest academic Doctors network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dailyrounds.org\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/f1f8f4904507b9ce4c90c65c9c06f454","name":"DailyRounds","url":"https:\/\/www.dailyrounds.org\/blog\/author\/minu\/"}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5KbfC-1n2","jetpack_featured_media_url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2019\/05\/Indiaindi.jpg","_links":{"self":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/5272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/comments?post=5272"}],"version-history":[{"count":1,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/5272\/revisions"}],"predecessor-version":[{"id":5274,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/5272\/revisions\/5274"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/media\/5273"}],"wp:attachment":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/media?parent=5272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/categories?post=5272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/tags?post=5272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}